283 related articles for article (PubMed ID: 19243481)
1. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany.
Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U
J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany. A comparison of calcipotriol/betamethasone (Daivobet/Dovobet/Taclonex) once daily and a morning/evening non-fix combination of calcipotriol and betamethasone.
Augustin M; Peeters P; Radtke M; Moehling U; Lapp C
Dermatology; 2007; 215(3):219-28. PubMed ID: 17823519
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Peeters P; Ortonne JP; Sitbon R; Guignard E
Dermatology; 2005; 211(2):139-45. PubMed ID: 16088161
[TBL] [Abstract][Full Text] [Related]
4. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
5. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.
Sawyer L; Samarasekera EJ; Wonderling D; Smith CH
Br J Dermatol; 2013 May; 168(5):1095-105. PubMed ID: 23374249
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of psoriasis therapy with etanercept in Germany.
Heinen-Kammerer T; Daniel D; Stratmann L; Rychlik R; Boehncke WH
J Dtsch Dermatol Ges; 2007 Sep; 5(9):762-8. PubMed ID: 17760896
[TBL] [Abstract][Full Text] [Related]
8. Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care?
Balkrishnan R; Bhosle MJ; Fleischer AB; Feldman SR
J Dermatolog Treat; 2010 May; 21(3):178-84. PubMed ID: 19821787
[TBL] [Abstract][Full Text] [Related]
9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
10. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
11. [Update of the topical treatment of psoriasis].
Carrascosa JM; Vanaclocha F; Borrego L; Fernández-López E; Fuertes A; Rodríguez-Fernández-Freire L; Zulaica A; Tuneu A; Caballé G; Colomé E; Bordas X; Hernanz JM; Brufau C; Herrera E
Actas Dermosifiliogr; 2009 Apr; 100(3):190-200. PubMed ID: 19457304
[TBL] [Abstract][Full Text] [Related]
12. Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care.
Marchetti A; Feldman SR; Kimball AB; Anderson RR; Miller LH; Martin J; An P
Dermatol Online J; 2005 Mar; 11(1):1. PubMed ID: 15748542
[TBL] [Abstract][Full Text] [Related]
13. Current effective topical therapies in the management of psoriasis.
Kurian A; Barankin B
Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834
[TBL] [Abstract][Full Text] [Related]
14. Topical steroids versus PUVA therapy in moderate plaque psoriasis: a clinical trial along with cost analysis.
Amirnia M; Khodaeiani E; Fouladi RF; Hashemi A
J Dermatolog Treat; 2012 Apr; 23(2):109-11. PubMed ID: 21254854
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
16. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
[TBL] [Abstract][Full Text] [Related]
17. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
18. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
[TBL] [Abstract][Full Text] [Related]
19. Calcipotriol cream: a review of its use in the management of psoriasis.
Segaert S; Duvold LB
J Dermatolog Treat; 2006; 17(6):327-37. PubMed ID: 17853305
[TBL] [Abstract][Full Text] [Related]
20. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]